Promises and challenges of personalized medicine to guide ARDS therapy.
Crit Care
; 25(1): 404, 2021 11 23.
Article
en En
| MEDLINE
| ID: mdl-34814925
ABSTRACT
Identifying new effective treatments for the acute respiratory distress syndrome (ARDS), including COVID-19 ARDS, remains a challenge. The field of ARDS investigation is moving increasingly toward innovative approaches such as the personalization of therapy to biological and clinical sub-phenotypes. Additionally, there is growing recognition of the importance of the global context to identify effective ARDS treatments. This review highlights emerging opportunities and continued challenges for personalizing therapy for ARDS, from identifying treatable traits to innovative clinical trial design and recognition of patient-level factors as the field of critical care investigation moves forward into the twenty-first century.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Dificultad Respiratoria
/
Medicina de Precisión
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Crit Care
Año:
2021
Tipo del documento:
Article